Pharvaris

PHVSNasdaq Netherlands Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.509 B

$36.02 -0.96%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

65,210,590

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#85Structure TherapeuticsGPCR$2.62B
#86HUTCHMED (China)HCM$2.53B
#87PharvarisPHVS$2.51B
#88Mineralys TherapeuticsMLYS$2.50B
#89Supernus PharmaceuticalsSUPN$2.49B

What if Pharvaris were worth as much as…

Open the what-if tool →

Gold $30.3T

$434,557.13

Per share 12,064× higher

Bitcoin $1.72T

$24,686.25

Per share 685× higher

Nvidia $5.48T

$78,658.49

Per share 2,184× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Pharvaris are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.